Cefuroxime
- Generic Name
- Cefuroxime
- Brand Names
- Ceftin
- Drug Type
- Small Molecule
- Chemical Formula
- C16H16N4O8S
- CAS Number
- 55268-75-2
- Unique Ingredient Identifier
- O1R9FJ93ED
- Background
Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, gonorrhea, and haemophilus.
- Indication
For the treatment of many different types of bacterial infections such as bronchitis, sinusitis, tonsillitis, ear infections, skin infections, gonorrhea, and urinary tract infections.
- Associated Conditions
- Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB), Animal bite, Bacterial Infections, Bone and Joint Infections, Impetigo, Lower Respiratory Tract Infection (LRTI), Lyme Disease, Maxillary Sinusitis, Meningitis, Neisseria Gonorrhoeae Infection, Septicemia, Skin and Subcutaneous Tissue Bacterial Infections, Urinary Tract Infection, Bacterial otitis media, Mild Streptococcal pharyngitis, Mild Streptococcal tonsillitis, Moderate Streptococcal pharyngitis, Moderate Streptococcal tonsillitis
- Associated Therapies
- -
An Open, Prospective, Randomized, Multicenter Study of the Efficacy and Safety of Intravenous Followed by Oral Azithromycin Versus Cefuroxime Alone or With Oral Erythromycin for the Treatment of Chinese Patients Who Were Hospitalized for Pneumonia
- Conditions
- Interventions
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2008-04-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 139
- Registration Number
- NCT00648726
- Locations
- 🇨🇳
Pfizer Investigational Site, Shanghai, China
Study of the Efficacy of Preoperative Cefuroxime Prophylaxis to Prevent Surgical Site Infection in Herniated Disk Surgery
- First Posted Date
- 2007-09-17
- Last Posted Date
- 2007-09-17
- Lead Sponsor
- Centre Hospitalier Universitaire Vaudois
- Target Recruit Count
- 1369
- Registration Number
- NCT00530400
- Locations
- 🇨🇭
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
🇨🇭Hôpitaux Universitaire de Genève, Geneva, Switzerland
Antibiotic Prophylaxis in Total Knee Prosthesis
- First Posted Date
- 2007-07-06
- Last Posted Date
- 2016-02-19
- Lead Sponsor
- Hospital Clinic of Barcelona
- Target Recruit Count
- 1332
- Registration Number
- NCT00497341
- Locations
- 🇪🇸
Hospital Clínic, Barcelona, Catalonia, Spain
Antibiotics for the Treatment of Ulcerative Colitis
- Conditions
- First Posted Date
- 2006-07-24
- Last Posted Date
- 2009-02-11
- Lead Sponsor
- University of Dundee
- Target Recruit Count
- 40
- Registration Number
- NCT00355602
- Locations
- 🇬🇧
Ninewells Hospital and Medical School, Dundee, Angus, United Kingdom
Prophylactic Antibiotic Treatment During Vaginal Repair
- Conditions
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2006-09-11
- Lead Sponsor
- Hvidovre University Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT00162604
- Locations
- 🇩🇰
Hvidovre University Hospital, Hvidovre, Denmark
Study of Antibiotic Prophylaxis for Endophthalmitis Following Cataract Surgery
- Conditions
- First Posted Date
- 2005-08-29
- Last Posted Date
- 2016-02-12
- Lead Sponsor
- City, University of London
- Target Recruit Count
- 35000
- Registration Number
- NCT00136344
- Locations
- 🇧🇪
University Hospital Antwerp, UZA Ophthalmology, Antwerp, Belgium
🇮🇹Ospedale Borgo Trento, Verona, Italy
🇧🇪Jan Yperman Ziekenhuis, Ieper, Belgium
Preventing Frequent Sinus Infections in HIV-Infected Patients
- Conditions
- Locations
- 🇺🇸
Univ of California / San Diego Treatment Ctr, San Diego, California, United States
🇺🇸Thomas Jefferson Univ Hosp, Philadelphia, Pennsylvania, United States
🇺🇸Stanford at Kaiser / Kaiser Permanente Med Ctr, San Francisco, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.